ACETYLCHOLINE RECEPTOR ACHR BINDING ANTIBODY Test
Test Name: ACETYLCHOLINE RECEPTOR ACHR BINDING ANTIBODY Test
Components: Price 510.0 AED
Sample Condition: 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen. Avoid general anaesthetic or muscle relaxant drugs 24 hours prior to sampling.
Report Delivery: 1 week
Method: Enzyme Immunoassay
Test type: Myasthenia Gravis
Doctor: Physician, Neurologist
Test Department: IMMUNOASSAY
Pre Test Information: Avoid general anaesthetic or muscle relaxant drugs 24 hours prior to sampling. This assay should not be requested for patients who have recently received radio-isotopes therapeutically or diagnostically due to potential assay interference.
Test Details
The Acetylcholine Receptor (AChR) Binding Antibody test is a laboratory test that measures the presence and levels of antibodies that bind to the acetylcholine receptors in the body. Acetylcholine receptors are found on the surface of muscle cells and play a crucial role in transmitting nerve signals to muscles, allowing them to contract.
This test is primarily used in the diagnosis of autoimmune conditions that affect the neuromuscular junction, such as myasthenia gravis. In myasthenia gravis, the immune system mistakenly produces antibodies that bind to and block the acetylcholine receptors, leading to muscle weakness and fatigue.
During the test, a blood sample is taken from the patient, and the serum is isolated. The serum is then tested for the presence of AChR binding antibodies using techniques such as enzyme-linked immunosorbent assay (ELISA) or radioimmunoassay (RIA).
A positive result indicates the presence of AChR binding antibodies, which suggests a diagnosis of myasthenia gravis or another autoimmune neuromuscular disorder. However, it is important to note that a negative result does not completely rule out the possibility of myasthenia gravis, as some patients may have the condition without detectable AChR antibodies. In such cases, additional testing may be necessary to confirm the diagnosis.
Overall, the AChR Binding Antibody test is a valuable tool in the diagnosis and management of myasthenia gravis and other autoimmune neuromuscular disorders. It helps healthcare providers determine the underlying cause of muscle weakness and tailor appropriate treatment plans for patients.
| Test Name | ACETYLCHOLINE RECEPTOR ACHR BINDING ANTIBODY Test |
|---|---|
| Components | |
| Price | 510.0 AED |
| Sample Condition | 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen. Avoid general anaesthetic or muscle relaxant drugs 24 hours prior to sampling. |
| Report Delivery | 1 week |
| Method | Enzyme Immunoassay |
| Test type | Myasthenia Gravis |
| Doctor | Physician, Neurologist |
| Test Department: | IMMUNOASSAY |
| Pre Test Information | Avoid general anaesthetic or muscle relaxant drugs 24 hours prior to sampling. This assay should not be requested for patients who have recently received radio-isotopes therapeutically or diagnostically due to potential assay interference. |
| Test Details | The Acetylcholine Receptor (AChR) Binding Antibody test is a laboratory test that measures the presence and levels of antibodies that bind to the acetylcholine receptors in the body. Acetylcholine receptors are found on the surface of muscle cells and play a crucial role in transmitting nerve signals to muscles, allowing them to contract. This test is primarily used in the diagnosis of autoimmune conditions that affect the neuromuscular junction, such as myasthenia gravis. In myasthenia gravis, the immune system mistakenly produces antibodies that bind to and block the acetylcholine receptors, leading to muscle weakness and fatigue. During the test, a blood sample is taken from the patient, and the serum is isolated. The serum is then tested for the presence of AChR binding antibodies using techniques such as enzyme-linked immunosorbent assay (ELISA) or radioimmunoassay (RIA). A positive result indicates the presence of AChR binding antibodies, which suggests a diagnosis of myasthenia gravis or another autoimmune neuromuscular disorder. However, it is important to note that a negative result does not completely rule out the possibility of myasthenia gravis, as some patients may have the condition without detectable AChR antibodies. In such cases, additional testing may be necessary to confirm the diagnosis. Overall, the AChR Binding Antibody test is a valuable tool in the diagnosis and management of myasthenia gravis and other autoimmune neuromuscular disorders. It helps healthcare providers determine the underlying cause of muscle weakness and tailor appropriate treatment plans for patients. |
